Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study

OBJECTIVE: To determine whether plasma levels of advanced glycation end products and oxidation products play a role in the development of atherosclerosis in patients with type 2 diabetes (T2D) over nearly 10 years of the VA Diabetes Trial and Follow-up Study. RESEARCH DESIGN AND METHODS: Baseline pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Saremi, Aramesh, Howell, Scott, Schwenke, Dawn C., Bahn, Gideon, Beisswenger, Paul J., Reaven, Peter D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360279/
https://www.ncbi.nlm.nih.gov/pubmed/28148544
http://dx.doi.org/10.2337/dc16-1875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360279/
https://www.ncbi.nlm.nih.gov/pubmed/28148544
http://dx.doi.org/10.2337/dc16-1875

Ejemplares similares